These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8924653)

  • 1. [in vitro comparison of liquid antacids of commercial use].
    Dominguez A; Diaz J; Monge C; Monge E
    Rev Gastroenterol Peru; 1996; 16(2):138-41. PubMed ID: 8924653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antacids: A comparison of their in vitro neutralizing capacity in hydrochloric acid and in acidified peptone solution (author's transl)].
    Walther C; Herzog P; Hissnauer KH; Kühl HJ; Holtermüller KH
    Z Gastroenterol; 1982 May; 20(5):263-72. PubMed ID: 7102017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of acid neutralizing efficacy of antacids in vitro].
    Kapralov NV; Sholomitskaia IA; Grinshpan DD; Nevar TN; Savitskaia TA; Boĭko AV
    Eksp Klin Gastroenterol; 2008; (3):44-8. PubMed ID: 19145882
    [No Abstract]   [Full Text] [Related]  

  • 4. [In vitro study of the neutralizing effect of the most frequently used antacids].
    Matincheva R; Antonov P; Kiratsov E
    Vutr Boles; 1983; 22(5):43-7. PubMed ID: 6689508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the methods of in vitro evaluation of the neutralizing properties of drugs from the antacid group].
    Pawlaczyk J; Kokot Z; Urbowicz G; Ewertowska D
    Acta Pol Pharm; 1989; 46(3):272-9. PubMed ID: 2618772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the neutralising capacity of eight brands of antacids.
    Hagos B; Nganga JN; Juma FD; Ndegwa P
    East Afr Med J; 1989 Jun; 66(6):408-10. PubMed ID: 2791947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Method of in vitro evaluation of the activity of antacids].
    Pawlaczyk J; Kokot Z
    Acta Pol Pharm; 1981; 38(2):223-8. PubMed ID: 7315466
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative evaluation of liquid antacids commercially available in the United Kingdom.
    Duffy TD; Fawzy SZ; Ireland DS; Rubinstein MH
    J Clin Hosp Pharm; 1982 Mar; 7(1):53-8. PubMed ID: 7096579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pepsin on the kinetics of HCl neutralization by dihydroxyaluminum sodium carbonate, hydrotalcite and dihydroxyaluminum aminoacetate.
    Kokot ZJ
    Acta Pol Pharm; 1991; 48(3-4):27-31. PubMed ID: 1669540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro determination of the neutralizing capacity of antacids].
    Brunner H
    Z Gastroenterol; 1983 Mar; 21 Suppl():22-5. PubMed ID: 6858407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of liquid antacid products.
    Sherrill MC; Rudd GD
    Am J Hosp Pharm; 1982 Feb; 39(2):300-2. PubMed ID: 7058802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparison of liquid antacids].
    Peled Y; Rattan J; Gilat T
    Harefuah; 1983 Sep; 105(5-6):110-2. PubMed ID: 6654255
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of antacids "in vitro"].
    Alvarez de Saldaña S; de Ramírez AF; Ramírez Mata M
    Rev Gastroenterol Mex; 1978; 43(3):127-30. PubMed ID: 33434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro comparison of acid-consuming capacity and duration of action of antacids.
    Packman EW; Gennaro AR
    Am J Pharm Sci Support Public Health; 1973; 145(5):162-4. PubMed ID: 4753131
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro buffering capacities of proprietary non-particulate antacids available in New Zealand.
    Watts DW
    Anaesth Intensive Care; 1994 Apr; 22(2):184-6. PubMed ID: 8210023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two antacid preparations on intragastric acidity--a two-centre open randomised cross-over placebo-controlled trial.
    Sulz MC; Manz M; Grob P; Meier R; Drewe J; Beglinger C
    Digestion; 2007; 75(2-3):69-73. PubMed ID: 17496418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid neutralization capacity of Canadian antacid formulations.
    MacCara ME; Nugent FJ; Garner JB
    Can Med Assoc J; 1985 Mar; 132(5):523-7. PubMed ID: 3971269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principles for development of antacids.
    Pilbrant A
    Scand J Gastroenterol Suppl; 1982; 75():32-6. PubMed ID: 6959248
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of systemic and local effects of nitric acid and hydrochloric acid: an experimental study in a rat model.
    Eray O; Eken C; Oktay C; Gelen T; Avci AB
    Ulus Travma Acil Cerrahi Derg; 2006 Jul; 12(3):184-8. PubMed ID: 16850355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of antacids.
    Engel GB
    N Z Med J; 1969 Feb; 69(441):80-2. PubMed ID: 5252206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.